Medical journal investigating study that wrongly… The publisher of some of the world's most prestigious scientific journals is investigating a study which claimed…
FDA pulls authorization for COVID antibody… Evusheld, the preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization…
RQ Bio partners with AstraZeneca in Covid… UK biotech RQ Bio is partnering with AstraZeneca as it races to keep its antibody to protect…
AstraZeneca’s preventative COVID treatment… The Food and Drug Administration (FDA) said on Friday that AstraZeneca’s preventative monoclonal antibody…
AstraZeneca drops submission to US regulators… AstraZeneca has abandoned its submission for US regulatory approval for the Covid-19 vaccine it developed…
Approval of AstraZeneca’s Evusheld COVID… Health Canada has approved AstraZeneca’s antibody combination Evusheld as a treatment for COVID-19, a…
AstraZeneca succeeds in last-ditch bid to stop… AstraZeneca has succeeded in an eleventh-hour effort to stop a former senior executive from joining rival…
U.S. Cancer Moonshot Needs Stronger Int’l Effort… Kevin Rudd, president of the Asia Society, introduces Antony Blinken, U.S. Secretary of State, at ...…
AstraZeneca sues former executive over move to… AstraZeneca has sued a former top business development executive to delay him taking a job at rival GSK,…